Cerus Corporation

Stock Chart, Company Information, and Scan Results

$2.59(as of Jun 23, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Cerus Corporation Company Information, Fundamentals, and Technical Indicators

Stock Price$2.59
Ticker SymbolCERS
ExchangeNasdaq
SectorHealthcare
IndustryMedical Devices
Employees261
CountyUSA
Market Cap$521.0M
EBIDTA-1.6M
10-Day Moving Average2.57
P/E Ratio-52.65
20-Day Moving Average2.68
Forward P/E Ratio0.00
50-Day Moving Average2.46
Earnings per Share-0.05
200-Day Moving Average2.02
Profit Margin-2.74%
RSI50.23
Shares Outstanding200.4M
ATR0.17
52-Week High3.15
Volume2,687,564
52-Week Low1.15
Most Recent Support Level2.41
Book Value68.3M
Most Recent Resistance Level2.73
P/B Ratio7.36
Upper Keltner3.07
P/S Ratio2.26
Lower Keltner2.29
Debt-to-Equity Ratio3.07
Next Earnings Date08/03/2026
Cash Surplus-79.5M
Next Ex-Dividend DateUnknown

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells intended for transfusion; INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced; and INTERCEPT Illuminator, an LED-based device for blood component treatment. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was formerly known as CERUS TECHNOLOGIES INC and changed its name to Cerus Corporation in July 1996. The company was incorporated in 1991 and is headquartered in Concord, California.

Cerus Corporation In Our Stock Scanner

As of Jun 24, 2026
example chart graphic
Scan Name: Long Legged DojiScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.